Skip to content

Addiction: all studies

Page 4 of 857: studies 31 to 40 of 8,563, newest first. Back to the addiction overview

Research

Efficacy of Mindfulness Integrated Cognitive Behavior Therapy for Psychological Distress among Patients with Substance Use Disorder: A Randomized Controlled Trial

Pakistan Journal of Positive Psychology August 3, 2026

Substance use disorders represent a significant public health concern in Pakistan, with methamphetamine showing increasing prevalence, particularly among adults. In light of the escalating incidence of methamphetamine-type stimulant (MTS) consumption observed in Pakistan, this research endeavor sought to assess the efficacy of Mindfulness integrated cognitive behavior therapy (MICBT) for...

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

Addiction August 3, 2026 Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova et al.

BACKGROUND AND AIMS: This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT; BPL-003) administered alongside psychological support and manualised cognitive behavioural...

Cannabis and cannabinoids for the treatment of mental and substance use disorders and symptoms: A systematic review and meta-analysis of experimental and observational studies.

Psychiatry Research August 1, 2026 C. Bharat, Xin-Tong Huang, G. Campbell et al.

BACKGROUND Interest in cannabinoids for mental and substance use disorders is increasing. We examined experimental and observational evidence for treating these disorders and their symptoms. METHODS Systematic review and meta-analysis (PROSPERO CRD42023467536). We searched CENTRAL, MEDLINE, Embase and PsycINFO to May 2025 for studies of cannabinoids in adults (≥18 years) with ADHD, anxiety,...

Social media addiction and mindfulness among adolescents in Haryana

International Journal of Psychology Sciences August 1, 2026 Pinki ., Sandeep Singh

Background: Adolescents’ life now revolves around social media, which offers them chances for amusement, education, and communication. But extreme use can effect in social media addiction (SMA), which is marked by obsessive use, lack of control, withdrawal symptoms, and interference with day-to-day activities. Adolescents (ages 10 to 19) are especially vulnerable because of social,...

Efficacy of Mindfulness-Based Cognitive Therapy (MBCT) Intervention for Emotion Dysregulation among Patients with Substance Use Disorder

Pakistan Journal of Positive Psychology July 29, 2026 Syeda Afeera, Sajid Iqbal Alyana

The present study examined the efficacy of Mindfulness-Based Cognitive Therapy (MBCT) in reducing emotion dysregulation among patients with SUD. A randomized controlled trial with a pre-test and post-test design was conducted at Umeed-e-Shifa Rehabilitation Centre, Bani Gala. Forty male participants aged 20–40 years meeting DSM-5-TR criteria for SUD were selected through purposive sampling and...

Mindfulness-based interventions in the treatment of behavioral addictions

IRIS July 28, 2026 Cora von Hammerstein, Joël Billieux preprint

Mindfulness is defined as nonjudgmental, nonreactive, metacognitive attention focused on the experience of the present moment, without being caught up in thoughts about the past or future (Garland, 2007). Mindfulness-based interventions are gaining growing interest in the field of clinical psychology. This third-wave cognitive behavioral therapy (CBT) has been shown to be effective in the...

Editorial: Emerging treatment approaches for substance use disorders

Frontiers in Psychiatry July 21, 2026 David Martinez Garza, Ilya O. Blokhin, Jonathan Brett et al.

Since the introduction of disulfiram in 1951 (the first ever Food and Drug Administration (FDA)-approved medication for substance use disorders (SUDs)) (1), only seven other individual medications have been approved for the treatment of SUDs. While the repurpose of medications and different formulations increase the total number of FDA-approved medicines (Table 1 and(2)), the arsenal of...

Ketamine for substance use disorders: a systematic review and meta-analysis

Frontiers in Psychiatry July 17, 2026 Shu-Ping Fang, Xin Yang, Da-Cong Zhao et al.

Introduction Substance use disorder (SUD) is a major global health issue, contributing significantly to the disease burden. Despite this, effective treatments for SUD remain limited. Ketamine has shown potential as a treatment, yet no meta-analysis has assessed its efficacy for SUD. This study aimed to evaluate the efficacy and safety of ketamine in treating SUD. Methods Multiple databases were...

DOI: 10.3389/fpsyt.2026.1835709 (opens in new tab) Ketamine Abstinence Adverse effect Randomized controlled trial +6

How Effective Are Mindfulness-Based Interventions (MBIs) for the Treatment of Substance Use Disorders (SUDs), Relapse Prevention, and Craving: An Umbrella Review Article.

Substance Use & Misuse July 15, 2026 Parvin Ajami Bakhtiarvand, Mohammad Reza Abedi

Substance use disorders (SUDs) affect the lives of more than 35 million people worldwide, according to 2019 data from the United Nations Office on Drugs and Crime. Current evidence suggests that MBIs may mitigate the harmful psychosocial effects associated with SUDs. Although MBIs have been extensively studied for efficacy, there remains a growing need to synthesize evidence from relevant...

DOI: 10.1080/10826084.2026.2699442 (opens in new tab) Full text (opens in new tab) Substance use disorders Craving reduction Meta-analysis Mindfulness-based interventions +2